Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer
US7351530B1 · kind B1 · utility
2Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 20, 2002 |
| Grant date | Apr 1, 2008 |
| Priority date | — |
| Expiry date | Feb 3, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides a method for detection of loss of heterozygosity (LOH) at human chromosome segment 11p15.5 in a tumor sample from a patient with non-small-cell lung cancer (NSCLC), and a method for prognosis of the patient's disease progression. The prognosis is useful for determining the course of treatment following surgical resection of tumor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.